IP Verse

Ipsen Biopharm Limited competitive analysis

Loading summary...

Latest oppositions filed by Ipsen Biopharm Limited

Explore patent oppositions filed by Ipsen Biopharm Limited against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 30, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3094331
Combination-Based Treatment MethodNEKTAR THERAPEUTICSSep 27, 2018

Latest patents of Ipsen Biopharm Limited opposed by its competitors

Explore Ipsen Biopharm Limited's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 30, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3796929
Sep 18, 2024Suppression Of Bone Cancer-Induced Allodynia1
EP3758611
Jul 24, 2024Use Of Ultrasound To Guide Injection Of Non-Cytotoxic Protease1
EP2939688
Feb 20, 2019Pharmaceutical Compositions Comprising Botulinum Neurotoxin1

Latest PTAB cases involving Ipsen Biopharm Limited

Discover the latest PTAB cases involving Ipsen Biopharm Limited, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Ipsen Biopharm Limited with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 30, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
IPSEN BIOPHARM110 - 2
ALLERGAN11291333
MERZ PHARMA176 - -
MERZ THERAPEUTICS1 - - -